1Y Close · As of Aug 26, 2026
JETEMA operates in the Pharmaceuticals sector.
Legal name: JETEMA Co.,Ltd.
In fiscal year 2025, JETEMA (216080) reported revenue of 76.9 billion KRW, up 12.2% from 68.5 billion KRW a year earlier.
Operating profit was 3.8 billion KRW and net income was -7.4 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 182.3 billion KRW, with a P/B of 2.81.
These figures can be verified in the DART filing (receipt no. 20260320000625).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 76.9B | 3.8B | -7.4B |
| 2024 | 68.5B | 4.1B | -2.6B |
| 2023 | 58.7B | 2.6B | 13.6B |
Recent Filings
Large Shareholding Report (General)
Large Shareholding Report (General)
Large Shareholding Report (General)
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Large Shareholding Report (General) |
| 2026-08-25 | Large Shareholding Report (General) |
| 2026-08-18 | Large Shareholding Report (General) |
| 2026-08-14 | Officer/Major Shareholder Ownership Report |
| 2026-08-14 | Officer/Major Shareholder Ownership Report |